SLC20A1
Basic information
Region (hg38): 2:112645939-112663825
Previous symbols: [ "GLVR1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC20A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 24 | 5 | 2 |
Variants in SLC20A1
This is a list of pathogenic ClinVar variants found in the SLC20A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-112646850-A-G | not specified | Uncertain significance (Apr 06, 2023) | ||
2-112646883-G-A | not specified | Uncertain significance (Apr 08, 2022) | ||
2-112646904-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
2-112647088-A-C | not specified | Uncertain significance (Aug 02, 2021) | ||
2-112647115-A-G | not specified | Uncertain significance (Dec 14, 2023) | ||
2-112647123-C-G | not specified | Uncertain significance (Apr 12, 2023) | ||
2-112647131-G-A | SLC20A1-related disorder | Benign (Oct 17, 2019) | ||
2-112647397-A-C | Likely benign (Nov 01, 2022) | |||
2-112647400-T-C | SLC20A1-related disorder | Likely benign (Aug 13, 2019) | ||
2-112647655-A-C | not specified | Uncertain significance (Mar 18, 2024) | ||
2-112652699-C-T | SLC20A1-related disorder | Likely benign (Apr 10, 2019) | ||
2-112652703-C-G | not specified | Uncertain significance (Dec 14, 2023) | ||
2-112652727-G-A | not specified | Uncertain significance (May 20, 2024) | ||
2-112652754-C-T | not specified | Uncertain significance (May 27, 2022) | ||
2-112652768-C-G | not specified | Uncertain significance (Jul 13, 2022) | ||
2-112652778-T-C | not specified | Uncertain significance (Oct 25, 2023) | ||
2-112657128-G-T | not specified | Uncertain significance (Nov 21, 2022) | ||
2-112657137-A-G | not specified | Uncertain significance (Sep 12, 2023) | ||
2-112657167-C-T | not specified | Uncertain significance (Oct 06, 2022) | ||
2-112658954-C-A | not specified | Uncertain significance (Dec 22, 2023) | ||
2-112658962-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
2-112659103-G-C | SLC20A1-related disorder | Likely benign (May 08, 2019) | ||
2-112659206-G-A | Benign (Oct 10, 2018) | |||
2-112659295-C-T | Likely benign (Nov 01, 2022) | |||
2-112659376-C-T | SLC20A1-related disorder | Likely benign (Aug 14, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC20A1 | protein_coding | protein_coding | ENST00000272542 | 10 | 17971 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0672 | 0.933 | 125717 | 0 | 31 | 125748 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.85 | 278 | 379 | 0.733 | 0.0000194 | 4431 |
Missense in Polyphen | 75 | 143.04 | 0.52435 | 1639 | ||
Synonymous | 0.219 | 137 | 140 | 0.976 | 0.00000757 | 1383 |
Loss of Function | 3.70 | 8 | 29.8 | 0.269 | 0.00000170 | 331 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00129 | 0.00129 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000794 | 0.0000791 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Sodium-phosphate symporter which plays a fundamental housekeeping role in phosphate transport, such as absorbing phosphate from interstitial fluid for normal cellular functions such as cellular metabolism, signal transduction, and nucleic acid and lipid synthesis. May play a role in extracellular matrix and cartilage calcification as well as in vascular calcification. {ECO:0000269|PubMed:11009570, ECO:0000269|PubMed:7929240, ECO:0000269|PubMed:7966619, ECO:0000269|PubMed:8041748}.;
- Pathway
- Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Sodium-coupled phosphate cotransporters
(Consensus)
Recessive Scores
- pRec
- 0.170
Intolerance Scores
- loftool
- 0.141
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.36
Haploinsufficiency Scores
- pHI
- 0.813
- hipred
- Y
- hipred_score
- 0.625
- ghis
- 0.514
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0621
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc20a1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; embryo phenotype; liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype;
Gene ontology
- Biological process
- phosphate-containing compound metabolic process;ion transport;biomineral tissue development;phosphate ion transmembrane transport;sodium ion transmembrane transport;positive regulation of I-kappaB kinase/NF-kappaB signaling;sodium-dependent phosphate transport
- Cellular component
- plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- inorganic phosphate transmembrane transporter activity;high-affinity inorganic phosphate:sodium symporter activity;sodium:phosphate symporter activity;sodium:inorganic phosphate symporter activity;sodium-dependent phosphate transmembrane transporter activity;signaling receptor activity